BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20440908)

  • 1. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components.
    Rowley S; MacLeod B; Heimfeld S; Holmberg L; Bensinger W
    Cytotherapy; 1999; 1(4):311-7. PubMed ID: 20440908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.
    Mueller LP; Theurich S; Christopeit M; Grothe W; Muetherig A; Weber T; Guenther S; Behre G
    Eur J Haematol; 2007 Jun; 78(6):527-31. PubMed ID: 17509106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade.
    Rowley SD; Feng Z; Yadock D; Holmberg L; Macleod B; Heimfeld S
    Cytotherapy; 1999; 1(6):439-46. PubMed ID: 20426544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
    Hoyt R; Szer J; Grigg A
    Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
    Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
    Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.
    Scheinkönig C; Kappicht S; Kolb HJ; Schleuning M
    Bone Marrow Transplant; 2004 Sep; 34(6):531-6. PubMed ID: 15286692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of autologous bone marrow graft infusion.
    Davis J; Rowley SD; Santos GW
    Prog Clin Biol Res; 1990; 333():531-40. PubMed ID: 2308999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft.
    Liseth K; Abrahamsen JF; Bjørsvik S; Grøttebø K; Bruserud Ø
    Cytotherapy; 2005; 7(4):328-33. PubMed ID: 16162454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation.
    Martin-Henao GA; Torrico C; Azqueta C; Amill B; Querol S; Garcia J
    Transfusion; 2005 Dec; 45(12):1917-24. PubMed ID: 16371044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases.
    Hernández-Navarro F; Ojeda E; Arrieta R; Ríos-Rull P; García-Bustos J; Quevedo E; Martín Hernández MP; Jiménez-Yuste V; Rodríguez-Luaces M; López RM; García-Miguel P; Martínez A; Sastre A; Calero F; Gómez-Pastrana F; Martínez B
    Bone Marrow Transplant; 1998 Mar; 21(5):511-7. PubMed ID: 9535044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells.
    Katayama Y; Yano T; Bessho A; Deguchi S; Sunami K; Mahmut N; Shinagawa K; Omoto E; Makino S; Miyamoto T; Mizuno S; Fukuda T; Eto T; Fujisaki T; Ohno Y; Inaba S; Niho Y; Harada M
    Bone Marrow Transplant; 1997 Feb; 19(3):283-7. PubMed ID: 9028559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis.
    Benekli M; Anderson B; Wentling D; Bernstein S; Czuczman M; McCarthy P
    Bone Marrow Transplant; 2000 Jun; 25(12):1299-301. PubMed ID: 10871736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
    Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.